# Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/par-21-248-pediatric-immune-system-ontogeny-and-development-intend-r01/  
Official notice: https://www.grants.gov/search-results-detail/334658

> National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on May 7, 2024.

| Field | Value |
|---|---|
| Opportunity number | PAR-21-248 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | May 7, 2024 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.865 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

## What the grant funds

The purpose of this Funding Opportunity Announcement (FOA) is to correlate immune systemdevelopment patterns between two or more age groups- neonates, infants, and children and adolescents and further understand the impact of infectious diseases, microbiome and environmental factors on ontogeny and development of pediatric immune system, from birth, transitioning into adolescence and adulthood with focus impact during pregnancy and post-natal period.

## Questions people ask

### Is PAR-21-248 still open?

No. It closed on May 7, 2024.

### Who can apply for Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)?

Closed May 7, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under PAR-21-248?

NIH RePORTER lists 5 projects funded under PAR-21-248 in fiscal 2022 to 2026, at 5 institutions. The most were at Research Inst Nationwide Children's Hosp, University of Washington, University of Vermont & St Agric College.

### Who has won Child Health and Human Development Extramural Research grants before?

The largest recipients over five fiscal years were Regents of the University of Michigan, The Johns Hopkins University, University of Washington. The program made 6,026 awards worth $6.0 billion in that time.